Hap Trading, LLC Edwards Lifesciences Corp Call Options Transaction History

Hap Trading, LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 12, 2024	BUY	$59.7 - $93.78 $15.1 Million - $23.7 Million	253,100 New	253,100 $32.3 Million
Q2 2022 Aug 12, 2022	BUY	$86.5 - $128.27 $1.26 Million - $1.87 Million	14,600 New	14,600 $27,000
Q1 2022 May 12, 2022	SELL	$101.96 - $128.34 $2.64 Million - $3.32 Million	-25,900 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $2.75 Million - $3.38 Million	25,900 New	25,900 $257,000
Q3 2021 Nov 10, 2021	SELL	$102.91 - $122.75 $1.03 Million - $1.23 Million	-10,000 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$83.84 - $104.76 $838,400 - $1.05 Million	10,000 New	10,000 $70,000
Q2 2020 Aug 10, 2020	SELL	$57.54 - $76.95 $650,202 - $869,535	-11,300 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$52.41 - $81.0 $592,233 - $915,300	11,300 New	11,300 $21,000
Q2 2019 Aug 14, 2019	SELL	$55.74 - $64.41 $4.06 Million - $4.7 Million	-72,900 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$47.89 - $64.05 $3.49 Million - $4.67 Million	72,900 New	72,900 $157,000

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.